EFFICACY AND SAFETY OF THERAPY WITH ATORVASTATIN IN HIGH DOSES

Large epidemiological trails shown that hypercholesterolemia is one of the main risk factor of ischemic heart disease (IHD). Correction of the hypercholesterolemia with GmGKoA reductase inhibitors (statins) essentially reduces IHD morbidity and mortality. The lower serum level of low density lipopro...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsman: A. N. Meshkov
Materialtyp: Artigo
Språk:Inglês
Publicerad: Stolichnaya Izdatelskaya Kompaniya 2016-01-01
Serie:Racionalʹnaâ Farmakoterapiâ v Kardiologii
Ämnen:
hypercholesterolemia
ischemic heart disease
atorvastatin
Länkar:https://www.rpcardio.com/jour/article/view/820
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk